ஆலிவர் ஹ்ம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆலிவர் ஹ்ம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆலிவர் ஹ்ம் Today - Breaking & Trending Today

WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries | ANP Pers Support

WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries | ANP Pers Support
perssupport.nl - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from perssupport.nl Daily Mail and Mail on Sunday newspapers.

United States , Republic Of , South Korea , Oliver Hao , Winhealth Pharma , Jack Wang , Wu Yuancheng , Anders Edvell , Winhealth Pharma Group Co Ltd , Prnewswire Hongkong Winhealth Pharma Group Co Ltd , Immedica Pharma , Greater China Area , North America , Cycle Disorder , Urea Cycle Disorders , Middle East , Health Pharma , ஒன்றுபட்டது மாநிலங்களில் , குடியரசு ஆஃப் , தெற்கு கொரியா , ஆலிவர் ஹ்ம் , பலா வாங் , அதிகமானது சீனா பரப்பளவு , வடக்கு அமெரிக்கா , மிதிவண்டி கோளாறு , யூரியா மிதிவண்டி கோளாறுகள் ,

WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti® in China and several other Asia-Pacific countries

Share this article
Share this article
STOCKHOLM and HANGZHOU, China, Dec. 30, 2020 /PRNewswire/ Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti
® (glycerol phenylbutyrate), in a territory covering the Greater China Area, South Korea, Singapore, Vietnam, Indonesia, Malaysia, Philippines and Thailand.
Ravicti
® is in Europe and North America indicated for treatment of urea cycle disorders (UCD), and under the announced partnership, WinHealth is granted a license to register and commercialize the product in UCD in the countries of the specified territory. ....

United States , Republic Of , South Korea , Oliver Hao , Winhealth Pharma , Jack Wang , Anders Edvell , Winhealth Pharma Group Co Ltd , Prnewswire Hongkong Winhealth Pharma Group Co Ltd , Winhealth Pharma Group , Immedica Pharma , Greater China Area , North America , Cycle Disorder , Urea Cycle Disorders , Middle East , Health Pharma , Pharma Group , Winhealth Pharma Group Hk , ஒன்றுபட்டது மாநிலங்களில் , குடியரசு ஆஃப் , தெற்கு கொரியா , ஆலிவர் ஹ்ம் , பலா வாங் , அதிகமானது சீனா பரப்பளவு , வடக்கு அமெரிக்கா ,

WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti in China and several other Asia-Pacific countries

(1)
STOCKHOLM and HANGZHOU, China, Dec. 31, 2020 /PRNewswire/ Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti
(glycerol phenylbutyrate), in a territory covering the Greater China Area, South Korea, Singapore, Vietnam, Indonesia, Malaysia, Philippines and Thailand.
Ravicti
is in Europe and North America indicated for treatment of urea cycle disorders (UCD), and under the announced partnership, WinHealth is granted a license to register and commercialize the product in UCD in the countries of the specified territory.
It is with great pleasure that we announce this partnership with WinHealth, under which we will be able to make Ravicti ....

United States , Republic Of , South Korea , Kostenloser Wertpapierhandel , Oliver Hao , Winhealth Pharma , Jack Wang , Anders Edvell , Winhealth Pharma Group Co Ltd , Prnewswire Hongkong Winhealth Pharma Group Co Ltd , Immedica Pharma , Greater China Area , North America , Cycle Disorder , Urea Cycle Disorders , Middle East , Health Pharma , Twin Health , ஒன்றுபட்டது மாநிலங்களில் , குடியரசு ஆஃப் , தெற்கு கொரியா , ஆலிவர் ஹ்ம் , பலா வாங் , அதிகமானது சீனா பரப்பளவு , வடக்கு அமெரிக்கா , மிதிவண்டி கோளாறு ,

WinHealth e Immedica llegan a un acuerdo para proporcionar a Winhealth los derechos de Ravicti®

WinHealth e Immedica llegan a un acuerdo para proporcionar a Winhealth los derechos de Ravicti®
europapress.es - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europapress.es Daily Mail and Mail on Sunday newspapers.

Republic Of , South Korea , South Koreans , Winhealth Pharma , Oliver Hao , Jack Wang , Contacts Winhealth Pharma Group , Hong Kong Winhealth Pharma Group , Winhealth And , China And , Gothenburg And Hangzhou , Europe And United States , From Ucd In China , Middle East , குடியரசு ஆஃப் , தெற்கு கொரியா , தெற்கு கொரியர்கள் , ஆலிவர் ஹ்ம் , பலா வாங் , சீனா மற்றும் , நடுத்தர கிழக்கு ,

WinHealth e Immedica llegan a un acuerdo para proporcionar a Winhealth los derechos de Ravicti®

WinHealth e Immedica llegan a un acuerdo para proporcionar a Winhealth los derechos de Ravicti®
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Republic Of , South Korea , South Koreans , Winhealth Pharma , Oliver Hao , Jack Wang , Contacts Winhealth Pharma Group , Hong Kong Winhealth Pharma Group , Winhealth Pharma Group , Winhealth And , China And , Gothenburg And Hangzhou , Europe And United States , From Ucd In China , Middle East , Pharma Group , குடியரசு ஆஃப் , தெற்கு கொரியா , தெற்கு கொரியர்கள் , ஆலிவர் ஹ்ம் , பலா வாங் , சீனா மற்றும் , நடுத்தர கிழக்கு , பார்மா குழு ,